Differential Wnt11 expression related to Wnt5a in high- and low-grade serous ovarian cancer: Implications for migration, adhesion and survival

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 3, 2014, Pages 1489-1495

  Jannesari Ladani, Farnaz ^a   Hossein, Ghamartaj ^a   Izadi Mood, Narges ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adhesion; Epithelial ovarian cancer; Migration; Viability; Wnt11; Wnt5a

Indexed keywords

ONCOPROTEIN; WNT PROTEIN; WNT11 PROTEIN, HUMAN; WNT5A PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CYSTADENOCARCINOMA; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; OVARY TUMOR; PATHOLOGY; PLASMID; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; OVARIAN NEOPLASMS; PLASMIDS; PROTO-ONCOGENE PROTEINS; TRANSFECTION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84896810295     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.3.1489     Document Type: Article

References (35)

1. Amin N, Vincan E (2012). The Wnt signaling pathways and cell adhesion. Front Biosci, 17, 784-804.
2. Badiglian Filho L, Oshima CT, De Oliveira Lima F, et al (2009). Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer. Oncol Rep, 21, 313-20.
3. Bartis D, Csongei V, Weich A, et al (2013). Down-regulation of canonical and up-regulation of non-canonical Wnt signalling in the carcinogenic process of squamous cell lung carcinoma. PLoS One, 8, 57393.
4. Bitler BG, Nicodemus JP, Li H, et al (2011). Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Cancer Res, 71, 6184-94.
5. Cao Q, Lu X, Feng YJ (2006). Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. Cell Res, 16, 671-7.
6. Cha SW, Tadjuidje E, Tao Q, Wylie C, Heasman J (2008). Wnt5a and Wnt11 interact in a maternal Dkk1-regulated fashion to activate both canonical and non-canonical signaling in Xenopus axis formation. Development, 135, 3719-29.
7. Cha SW, Tadjuidje E, White J, et al (2009). Wnt11/5a complex formation caused by tyrosine sulfation increases canonical signaling activity. Curr Biol, 19, 1573-80.
8. Dwyer MA, Joseph JD, Wade HE, et al (2010). WNT11 expression is induced by estrogen-related receptor α and β-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res, 70, 9298-308.
9. Eisenberg CA, Eisenberg LM (1999). WNT11 promotes cardiac tissue formation of early mesoderm. Dev Dyn, 216, 45-58.
10. Flaherty MP, Abdel-Latif A, Li Q, et al (2008). Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation, 117, 2241-52.
11. Katoh M (2009). Integrative genomic analyses of WNT11: transcriptional mechanisms based on canonical WNT signals and GATA transcription factors signaling. Int J Mol Med, 24, 247-51.
12. Kirikoshi H, Sekihara H, Katoh M (2001). Molecular cloning and characterization of human WNT11. Int J Mol Med, 8, 651-6.
13. Liu JX, Hu B, Wang Y, Gui JF, Xiao W (2009). Zebrafish eaf1 and eaf2/u19 mediate effective convergence and extension movements through the maintenance of wnt11 and wnt5 expression. J Biol Chem, 284, 16679-92.
14. Majumdar A, Vainio S, Kispert A, McMahon J, McMahon AP (2003). Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development, 130, 3175-85.
15. Matei D, Graeber TG, Baldwin RL, et al (2002). Gene expression in epithelial ovarian carcinoma. Oncogene, 21, 6289-98.
16. Maye P, Zheng J, Li L, Wu D (2004). Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway. J Biol Chem, 279, 24659-65
17. McDonald SL, Silver A (2009). The opposing roles of Wnt-5a in cancer. Br J Cancer, 101, 209-14.
18. Medrek C, Landberg G, Andersson T, Leandersson K (2009). Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/Ecadherin complex formation and intercellular adhesion in human breast epithelial cells. J Biol Chem, 284, 10968-79.
19. Mikels AJ, Nusse R (2006). Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol, 4, 115.
20. Nagy II, Railo A, Rapila R, et al (2010). Wnt-11 signalling controls ventricular myocardium development by patterning N-cadherin and beta-catenin expression. Cardiovasc Res, 85, 100-9.
21. Ouko L, Ziegler TR, Gu LH, Eisenberg LM, Yang VW (2004). Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. J Biol Chem, 279, 26707-15.
22. Peng C, Zhang X, Yu H, Wu D, Zheng J (2011). Wnt5a as a predictor in poor clinical outcome of patients and a mediator in chemoresistance of ovarian cancer. Int Gynecol Cancer, 21, 280-8.
23. Pepicelli CV, Kispert A, Rowitch DH, Mcmahon AP (1997). GDNF induces branching and increased cell proliferation in the ureter of the mouse. Dev Biol, 192, 193-8.
24. Pukrop T, Binder C (2008). The complex pathways of Wnt5a in cancer progression. J Mol Med, 86, 259-66.
25. Railo A, Nagy II, Kilpelainen P, Vainio S (2008). Wnt-11 signaling leads to downregulation of the Wnt/beta-catenin, JNK/AP-1 and NF-kappaB pathways and promotes viability in the CHO-K1 cells. Exp Cell Res, 314, 2389-99.
26. Ricken A, Lochhead P, Kontogiannea M, Farookhi R (2002). Wnt signaling in the ovary: Identification and compartmentalized expression of-Wnt-2, Wnt-2b and frizzled-4 mRNAs. Endocrinology, 143, 2741-9.
27. Tada M, Concha ML, Heisenberg CP (2002). Non-canonical Wnt signalling and regulation of gastrulation movements. Semin Cell Dev Biol, 13, 251-60.
28. Toyama T, Lee HC, Koga H, Wands JR, Kim M (2010). Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Mol Cancer Res, 8, 254-65.
29. Ueno K, Hazama S, Mitomori S, et al (2009). Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer, 101, 1374-81.
30. Usongo M, Li X, Farookhi R (2013). Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression. Dev Dyn, 242, 291-300.
31. Uysal-Onganer P, Kawano Y, Caro M, et al (2010). Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol Cancer, 10, 9-55.
32. Uysal-Onganer P, Kypta RM (2011). Wnt11 in 2011-the regulation and function of a non-canonical Wnt. Acta Physiologica, 204, 52-64.
33. Yuzugullu H, Benhaj K, Ozturk N, et al (2009). Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer, 22, 8-90.
34. Zhou W, Lin L, Majumdar A, et al (2007). Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2. Nat Genet, 39, 1225-34.
35. Zhu H, Mazor M, Kawano Y, et al (2004). Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor. Cancer Res, 64, 7918-26.